Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | MIG | 141.0 | 53 | |
RA1869 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | MIG | 42.0 | 51 | |
RA1869 | TNF-a | 100 | ng/mL | 1 | MIG | 56.0 | 59 | ||||
N2759 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | MIG | 338.0 | 60 | |
N2759 | TNF-a | 100 | ng/mL | 1 | MIG | 268.0 | 66 | ||||
RA1931 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | MIG | 78.5 | 68 | |
RA1931 | TNF-a | 100 | ng/mL | 1 | MIG | 87.5 | 56 | ||||
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | MIG | 190.0 | 33 | |
N2586 | TNF-a | 100 | ng/mL | 1 | MIG | 223.0 | 57 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIG | 24.0 | 49 | |
RA1869 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIG | 23.0 | 46 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIG | 62.0 | 69 | |
N2759 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIG | 94.0 | 66 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIG | 27.5 | 64 | |
RA1931 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIG | 28.0 | 52 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIG | 53.5 | 60 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIG | 48.5 | 64 | |
RA1869 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIG | 44.0 | 49 | |
RA1869 | IL-1 alpha | 100 | ng/mL | 1 | MIG | 35.5 | 44 | ||||
N2759 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIG | 138.5 | 68 | |
N2759 | IL-1 alpha | 100 | ng/mL | 1 | MIG | 122.0 | 49 | ||||
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIG | 50.0 | 46 | |
RA1931 | IL-1 alpha | 100 | ng/mL | 1 | MIG | 46.0 | 53 | ||||
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIG | 141.0 | 39 | |
N2586 | IL-1 alpha | 100 | ng/mL | 1 | MIG | 119.5 | 42 |